SEC Form 4 · accession 0001209191-18-060492
TANDEM DIABETES CARE INC · TNDM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Edward L Cahill
Director
Period of report
Nov 28, 2018
Accepted (ET)
Nov 30, 2018 · 8:37 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001438133
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Nov 28, 2018 | J | 173,916 | $0.00 | D | 0 | I | By HLM Venture Partners II, L.P. |
| Common StockF1,F2 | Nov 28, 2018 | J | 17,400 | $0.00 | A | 17,400 | I | By HLM Venture Associates II, L.L.C. |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents a pro-rata in-kind distribution of Common Stock of the Issuer by HLM Venture Partners II, L.P. effected following the close of the trading market on November 28, 2018 without consideration to its limited partners and its general partner, HLM Venture Associates II, L.L.C. As a result of the distribution, HLM Venture Associates II, L.L.C. is the beneficial owner of 17,400 shares of common stock of the issuer.
- F2HLM Venture Associates II, L.L.C. is the general partner of HLM Venture Partners II, L.P. The Reporting Person is a managing member of HLM Venture Associates II, L.L.C. and, as such, may be deemed to have shared voting and dispositive power with respect to the issuer's securities held of record by HLM Venture Partners II, L.P. The Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of his respective pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the shares for purposes of Section 16 or for any other purpose.